TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biospecialisten Sverige AB
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
87
|
108
|
192 |
| Financial expenses |
3
|
1
|
1 |
| Earnings before taxes |
-6
|
-10
|
17 |
| EBITDA |
1
|
-8
|
25 |
| Total assets |
42
|
40
|
37 |
| Current assets |
8
|
11
|
19 |
| Current liabilities |
32
|
23
|
9 |
| Equity capital |
10
|
16
|
28 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
23.8%
|
40.0%
|
75.7% |
| Turnover per employee |
87
|
108
|
192 |
| Profit as a percentage of turnover |
-6.9%
|
-9.3%
|
8.9% |
| Return on assets (ROA) |
-7.1%
|
-22.5%
|
48.6% |
| Current ratio |
25.0%
|
47.8%
|
211.1% |
| Return on equity (ROE) |
-60.0%
|
-62.5%
|
60.7% |
| Change turnover |
-16
|
-67
|
29 |
| Change turnover % |
-16%
|
-38%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.